Leaderboard
Anzeige
medline.ch
En
|
De
Impressum
No articles selected!
View Cart
You are here:
Oncology
»
Skin
06. November 2026
Search
medline.ch
Skin
Advanced search
Dermatology
Endocrinology
Nutrition
Gastroenterology
Gynecology
Haematology
Infectious diseases
Cardiovascular Diseases
Musculoskeletal Diseases
Neurology
Oncology
Musculoskeletal System
Blood
Endocrine System
Gynecologic Neoplasms
Skin
Gastrointestinal
ORL
Respiratory Tract
Urologic Neoplasms
CNS
ORL
Pediatrics
Psychiatry
Respiratory Tract
Sports
Urology-Nephrology
Rect Top
Anzeige
Zoom:
Page 1 of 7282
Articles 1 - 20 / 145626
Neoadjuvant therapy in resectable cutaneous melanoma: a systematic review and meta-analysis of 35 trial arms.
Melanoma Res
Petrelli F, Ghidini A, Zambelli A, Merelli B.
PMID: 42989947 [PubMed - as supplied by publisher]
Discordant Primary Tumor and Nodal Response After Neoadjuvant Chemoimmunotherapy Identifies an Adverse Postoperative Subgroup in Esophageal Squamous Cell Carcinoma.
Cancer Med
Qian Y, Ren Y, Xu Z, Li R, Feng Y, Ding H, Zhang Y, Xia W, Xu L, Dong G, Jiang F.
PMID: 42989514 [PubMed - indexed for MEDLINE]
Can Multiparametric Digital Whole-Slide Image Analysis Improve Recurrence Risk Stratification in Oral Tongue Squamous Cell Carcinoma?
Cancer Med
Heusinger T, Cs, Cs, Mirbagheri H, Dörrich M, Kist AM, Grundtner P, Beyer S, Eckstein M, Gostian AO.
PMID: 42989449 [PubMed - indexed for MEDLINE]
Longitudinal MRI-based Delta-Habitat model for predicting pathological complete response to neoadjuvant chemoimmunotherapy in head and neck squamous cell carcinoma.
Cancer Imaging
Huang F, Yang X, Wang M, Yang L, Yang L, Aili A, Yang L, Zhong X, Duan X, Zhang F.
PMID: 42989416 [PubMed - indexed for MEDLINE]
Candida species colonisation as an independent or synergistic risk factor for oral cancer among betel quid, tobacco, and/or alcohol users: a protocol for a systematic review and meta-analysis.
Syst Rev
Fonseka V, Meepage HA, Hewage SA, Weerasekera MM, Seneviwickrama M.
PMID: 42989320 [PubMed - indexed for MEDLINE]
Association between preoperative monocyte-to-HDL cholesterol ratio and postoperative atrial fibrillation after esophagectomy for ESCC: a propensity score-matched retrospective cohort study.
J Cardiothorac Surg
Zhang Z, Liu H, Xia B, He W, Ma Q, Zhong Y, Zhu Y.
PMID: 42989314 [PubMed - indexed for MEDLINE]
Quantifying the social net: a nomogram to predict baseline quality of life at clinical entry for head and neck cancer.
World J Surg Oncol
Chakrawal A, Kr S, Pandey M.
PMID: 42989264 [PubMed - indexed for MEDLINE]
Evaluation of the Clinical Utility of Circulating Tumor DNA in the Management of Patients With Nonmetastatic Head and Neck Cancer: Protocol for a Prospective Bicentric Study (CIRVAD).
JMIR Res Protoc
Mastronicola R, Bresson M, Gravante G, Cortese S, Beulque E, Chergui F, Harlé A, Dolivet G.
PMID: 42987275 [PubMed - indexed for MEDLINE]
Carcinoma In Situ Skip Lesions of the Uterine Corpus in Cervical Squamous Cell Carcinoma: Impact on Target Setting in Radiotherapy.
Cancer Rep (Hoboken)
Harada M, Hagiwara Y, Kabasawa T, Sato H, Ichikawa M, Akamatsu H, Kaneko T, Yano N, Uematsu K, Komatsu M, Tanae T, Nemoto K, Koto M.
PMID: 42985977 [PubMed - indexed for MEDLINE]
Single-Cell and Spatial Insights into Oral Squamous Cell Carcinoma: Towards Cell-State-Targeted Immunotherapy.
Oncol Res
Chen Y, Hou L.
PMID: 42984972 [PubMed - indexed for MEDLINE]
Multiple sources, shared readouts: the attribution gap in circular RNA immunotherapy for esophageal squamous cell carcinoma.
Front Immunol
Li Z, Wang J, Lv H, Zhang F, Sun B, Huang C, Liu Z, Tian Z.
PMID: 42984690 [PubMed - indexed for MEDLINE]
Tumor budding and tumor-associated lymphocytic response as histopathological indicators of high-risk disease in head and neck cutaneous squamous cell carcinoma.
BMC Cancer
Aksu D, Yalç, Karasu N, Kuzu S, Özdemir Ç, Aksu U.
PMID: 42983664 [PubMed - indexed for MEDLINE]
Tumor-stromal ratio as a predictive marker for lymph node metastasis in patients with oral cavity squamous cell carcinoma: a cross-sectional study.
BMC Cancer
Muthuvel R, Saheb MIM, A N G, M SK.
PMID: 42983321 [PubMed - indexed for MEDLINE]
Neoadjuvant pepinemab in combination with nivolumab and/or ipilimumab in resectable metastatic melanoma: a pilot biomarker-driven trial.
Nat Commun
Ruffin AT, Mallow CL, Olson BM, Hammons J, Melendez B, Chelvanambi M, Gersz EM, Wittling MC, Diggs LP, Reilly C, Switchenko JM, Lazar AJ, Swisher SK, Kim J, Burns B, Harutyunyan A, Fisher TL, Delman KA, Yushak ML, Parker DC, Lawson D, Wargo JA, Zauderer M, Evans EE, Paulos CM, Lowe MC, Lesinski GB.
PMID: 42982815 [PubMed - indexed for MEDLINE]
Explainable computational framework for subtype classification and biomarker identification in head and neck squamous cell carcinoma using machine learning.
PLoS One
Rajan A, Biji CL, Sinha MG, Oviya IR.
PMID: 42981280 [PubMed - indexed for MEDLINE]
Therapeutic Hybrid Intelligence with Neural and Knowledge-based Expert Reasoning for SRS (THINKERS): an AI model for melanoma brain metastases.
Neurosurg Rev
Reyes JS, Bouras A, Lunsford LD, Niranjan A, Hadjipanayis CG.
PMID: 42980889 [PubMed - indexed for MEDLINE]
M0K0 M1K1 Grading System for Oral Squamous Cell Carcinoma - A Retrospective Study.
Indian J Dent Res
Natarajan S, Nandita KP, Boaz K, Lewis A, Manaktala N, Pai S.
PMID: 42980262 [PubMed - indexed for MEDLINE]
EDRIC-associated immune injury correlates with one-third of the survival detriment of elective nodal irradiation in esophageal squamous cell carcinoma.
Front Immunol
Ren X, Li L, Fan X, Zhu S, Yang H, Deng W, Liu L, Han C, Wang L.
PMID: 42979186 [PubMed - indexed for MEDLINE]
Closing the adaptive window: immune-metabolic strategies to constrain melanoma therapy resistance.
Front Immunol
Riccardo F, Conti L, Defilippi P, Arina P, Audrito V, Calautti E.
PMID: 42979158 [PubMed - indexed for MEDLINE]
Cutaneous metastasis in laryngeal squamous cell carcinoma: a case report and review of the literature.
J Med Case Rep
Zhang X, Lv H, Zou Y, Zhao H, Liu J.
PMID: 42978003 [PubMed - indexed for MEDLINE]
Articles 1 - 20 / 145626
Page 1 of 7282
Rect Bottom
Anzeige
Adserver Footer
Time frame
--unlimited--
1 Week
1 Month
3 Months
6 Months
1 Year
2 Years
3 Years
5 Years
10 Years
Sky right 1
Anzeige
Mediscope AG E-mail:
info@mediscope.ch
Disclaimer
|
Privacy Policy